Skip to main content

Table 2 Outcomes results of the aspirin and non-aspirin therapy groups

From: Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study

  Variable Aspirin
N = 154
Non-aspirin
N = 609
Crude odds ratio Adjusted odds ratio
  OR 95 % CI P value OR 95 % CI P value
Categorical ICU mortality n (%) 32 (20.8) 95 (15.6) 1.42 0.91,2.22 0.12 1.18 0.69, 2.02 0.55
Hospital mortality n (%) 62 (40.3) 180 (29.6) 1.61 1.11,2.32 0.01 0.95 0.61, 1.50 0.82
Sepsis n (%) 56 (36.4) 256 (42.04) 0.79 0.55,1.36 0.20 1.18 0.76, 1.84 0.45
Severe sepsis n (%) 51 (33.1) 182 (29.9) 1.16 0.80,1.70 0.44 1.70 1.08, 2.70 0.02
28 day mortality n (%) 19 (30.7) 31 (17.4) 2.09 1.08,4.07 0.02 1.41 0.65, 3.05 0.39
180 day mortality n (%) 50 (34.1) 128 (22.7) 1.75 1.18, 2.60 0.005 0.72 0.43, 1.21 0.22
Continuous     point estimate 95 % CI P value point estimate 95 % CI P value
MV duration (days) 11.17 ± 14.92 9.60 ± 9.05 1.58 −0.28, 3.44 0.09 2.7 0.51, 4.90 0.02
ICU LOS (days) 12.4 ± 15.2 10.8 ± 9.5 1.7 −0.27, 3.58 0.09 2.67 0.38,4.96 0.02
Hospital LOS (days) 65.6 ± 107.2 58.4 ± 81.7 7.22 −8.3, 22.7 0.36 12.5 −5.90, 30.96 0.18
  1. CI Confidence interval, MV Mechanical ventilation, OR Odds ratio